Dotmatics Cloud Hosted Platform Enables AstraZeneca PLC (AZN) Neuroscience Drug Discovery Collaborations
7/25/2013 9:50:56 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
BISHOPS STORTFORD, England--(BUSINESS WIRE)--Dotmatics announced today that the AstraZeneca Neuroscience Innovative Medicines Unit (iMed) has selected its Cloud based informatics platform as their research data management solution. The Dotmatics platform provides a single point of access to all data and functions across multidisciplinary groups. The platform includes compound registration and tracking, biological screening, DMPK analysis, as well as a fully integrated chemistry and biology ELN and project management. This flexibility enables AstraZeneca scientists, collaborators and partners to instantly interact with the same data regardless of location and timezone, fulfilling the promise of real time research.
Help employers find you! Check out all the jobs and post your resume.
comments powered by